WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORS →

DONATE →

CONTACT →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SPRING ADVOCACY DAYS 2024 →

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DONATE NOW →

CONTACT →

Latest News

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Empowering Young Voices: The Role of Youth in Kidney Cancer Advocacy

Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...

KCRS: KIDNEY CANCER RESEARCH SUMMIT →

RESEARCH OPPORTUNITIES →

NEWS →

Latest News

Renée Maria Saliby: Kidney Cancer Research Champion

Renée Maria Saliby: Kidney Cancer Research Champion

Introducing Renée Maria Saliby, a dedicated young investigator in kidney cancer research! At just 27, Renée is blazing an inspring professional trail. Read on as she shares insights from her personal experiences and career pursuits, along with opportunities available for young researchers to...

SUPPORT OUR WORK →

ROCK THE RUN 2023 →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

The U.S. House Appropriations Committee released its report accompanying the FY20 Defense Appropriations Act.

It contains an increase to $30 million annually for the kidney cancer research program.

Led by KidneyCan, a coalition of patients, caregivers and representatives of other patient advocacy organizations all pitched in to advocate for this much needed increase in research for a cure.

The increase still needs House and Senate approval along with the President’s signature to become law. We have a ways to go to the finish line but this is an important step in the process. Historically, figures included in the House bill ultimately become law.

The Kidney Cancer Research (KCRP) within the CDMRP table starts on p. 303:

https://appropriations.house.gov/sites/democrats.appropriations.house.gov/files/FY2020%20Defense%20Report%20Draft.pdf